Chapter 26: Problem 2
What is the difference between parkinsonian syndrome and Parkinson's disease?
Short Answer
Step by step solution
Key Concepts
These are the key concepts you need to understand to accurately answer the question.
Chapter 26: Problem 2
What is the difference between parkinsonian syndrome and Parkinson's disease?
These are the key concepts you need to understand to accurately answer the question.
All the tools & learning materials you need for study success - in one app.
Get started for freeWhich statement about experimental models of Parkinson's disease is true? a. Both genetic and toxic models exist, but only the former are commonly used. b. Inflammation has been described in all popular models of Parkinson's disease. c. The MPTP monkey model suggests that an acute intoxication produces an acute neurodegenerative event that is completed in a few days. d. The MPTP mouse model suggests that the toxin peosokes inflammation, which, in turn, kills dopaminergic neurons. e. Neuronophagia which suggests ongoing inflammation has been described in genetics, but not in toxic models of Parkinson's disease.
Which of the following statements is true about inflammation in Parkinson's disease? a. Free neuromelanin fails to activate microglia. b. Astrocytosis is as robust as microgliosis. c. The propensity of the different dopaminergic structures to degenerate in Parkinson's disease correlates with the basal density of glial cells. d. Both prostaglandin and alpha-synuclein count among the factors potentially responsible for triggering inflammation in Parkinson's disease. e. It is proven that prenatal infection and subsequent inflammation predispose one to Parkinson's disease.
Name the three theories about the detrimental role of inflammation in \(\mathbf{P D}\) and explain their respective basis.
Regarding the cytotoxicity of inflammation, which statement is not correct? a. Both oxygen and nitrogen reactive species can participate in the deleterious effects of inflammation. b. Inactivation of NADPH-oxidase, but not of nitric oxide synthase matigates MPTP-induced neurodegeneration in mice. c. The detrimental effects of inflammation on dopaminergic neurons can be mediated by soluble factors. d. Astrocytes and microglial cells can mutually modulate their degree of activation. e. Dopaminergic neurons express receptors for various deleterious cytokines.
Glial cells can exacerbate neurodegeneration in Parkinson's disease by? a. Losing their ability to assist neighboring neurons. b. Accelerating the demise of compromised neurons. c. A process of indiscriminate toxicity. d. Decreasing extracellular glutamate levels. e. \(\mathrm{a}, \mathrm{b}\) and \(\mathrm{c}\)
What do you think about this solution?
We value your feedback to improve our textbook solutions.